Smithers, a bioanalytical contract research organization (CRO), understands the unique bioanalytical and regulatory challenges inherent to bi-specific antibody development and has performed bioanalytical analysis for bi- and multi-specific antibodies at various stages of pre- and clinical development. Services include discovery bioassay, ADA assay, PK, Nab and ultra-sensitive biomarker services.
- Immunogenicity Assays
- Bioassays
- Biomarkers Test Development
- Generic PK/TK Assay to Support Development of Large Molecules and Biosimilars
- Immuno-Oncology Assays
- Monoclonal/Polyclonal Antibody Assays
- CAR-T and TCR Assays For Cellular Therapeutic Support
- Bi-specific antibodies
- Biobetters and Biosimilars
- Bioanalytical Testing Instrumentation
- Lab Automation Equipment